🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the safety and tolerability of...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-09
Trial ID
NCT02176486
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
The purpose of this study is to characterize the single-dose pharmacokineti...
Status
Completed
Location
Winship Cancer Institute, Emory University
Start Date
2013-09-16
Trial ID
NCT01830816
Treatments Being Tested
This is an open-label, multicenter, sequential, 5-arm, phase 1 study of ora...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-10
Trial ID
NCT01454076
The purpose of this study is to provide continued access of ixazomib and/or...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2012-12-26
Trial ID
NCT01659658
Treatments Being Tested
This is a phase 1, 2-part, pharmacokinetic study in patients with advanced ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01912222
Treatments Being Tested
This is a phase 1, 2-part, open-label study in 4 to 6 pharmacokinetic-evalu...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-19
Trial ID
NCT01953783
Treatments Being Tested
The purpose of this phase 1/2, open-label study was to evaluate the effect ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-27
Trial ID
NCT01335685
Treatments Being Tested